The Opportunity exists for Wholesalel investors to express interest in GT Metabolic Solutions (GT). 

Obesity is a Global epidemic, one of the leading factors for premature death in the developed world. In the USA, an estimated 42% of adults were obese in 2017 and linear time trend forecasts suggest that by 2030, 51% of the American population will be obese.  It is a health crisis which is linked with over forty other diseases including Diabetes, Heart disease, Stroke and Cancer which puts incredible pressure and cost on health systems. However Obesity is treatable and manageable. Bariatric Surgery removes a part of the stomach reducing food consumption and helping weight loss. The surgery is proven to work and deliver durable results but the market needs additional technologies to evolve, too few options exist for the surgeon and patients are stuck.

GT Metabolic Solutions The company develops technology which enables a new portfolio of procedures that will complement and expand the market by adapting the procedure to be less invasive, more efficient and less expensive. GT has a team of award winning industry leaders, that is experienced in the development and management of medical technologies and includes entrepreneurs and medical professionals. The size of the market is estimated at USD 3billion.

GT Metabolic Solutions is looking to raise USD15 million, raised funds will be used to take the company through initial Clinical Trials to a commercialization approval.

For more information you can access the investor deck by clicking the Documents tab.

You can also be connected with the US based advisors by clicking the register Interest button.